|
Adverse Effects
Citations 31-40 of 42 total displayed.
|
Past content
(since Sep 2000):
|
- Original Articles
An Assessment of the Independent Effects of Olanzapine and Risperidone Exposure on the Risk of Hyperlipidemia in Schizophrenic Patients
- Carol E. Koro; Donald O. Fedder; Gilbert J. L'Italien; Sheila Weiss; Laurence S. Magder; Julie Kreyenbuhl; Dennis Revicki; Robert W. Buchanan
Arch Gen Psychiatry 2002; 59: 1021-1026.
[Abstract]
[Full text]
[PDF]
- Original Articles
A Double-blind, Placebo-Controlled Dose-Response Comparison of Intramuscular Olanzapine and Haloperidol in the Treatment of Acute Agitation in Schizophrenia
- Alan Breier; Karena Meehan; Martin Birkett; Stacy David; Iris Ferchland; Virginia Sutton; Cindy C. Taylor; Rebecca Palmer; Martin Dossenbach; Geri Kiesler; Shlomo Brook; Padraig Wright
Arch Gen Psychiatry 2002; 59: 441-448.
[Abstract]
[Full text]
[PDF]
- Original Articles
Abnormalities in Glucose Regulation During Antipsychotic Treatment of Schizophrenia
- John W. Newcomer; Dan W. Haupt; Robert Fucetola; Angela K. Melson; Julie A. Schweiger; Benjamin P. Cooper; Gregg Selke
Arch Gen Psychiatry 2002; 59: 337-345.
[Abstract]
[Full text]
[PDF]
- Original Articles
Antipsychotics and the Risk of Sudden Cardiac Death
- Wayne A. Ray; Sarah Meredith; Purushottam B. Thapa; Keith G. Meador; Kathi Hall; Katherine T. Murray
Arch Gen Psychiatry 2001; 58: 1161-1167.
[Abstract]
[Full text]
[PDF]
- Commentaries
Sudden Cardiac Death and Antipsychotic Drugs: Do We Know Enough?
- Carlos A. Zarate Jr; Jayendra Patel
Arch Gen Psychiatry 2001; 58: 1168-1171.
[Extract]
[Full text]
[PDF]
- Original Articles
Clozapine Use in Patients With Schizophrenia and the Risk of Diabetes, Hyperlipidemia, and Hypertension: A Claims-Based Approach
- Brian C. Lund; Paul J. Perry; John M. Brooks; Stephan Arndt
Arch Gen Psychiatry 2001; 58: 1172-1176.
[Abstract]
[Full text]
[PDF]
- Original Articles
Melatonin Treatment for Tardive Dyskinesia: A Double-blind, Placebo-Controlled, Crossover Study
- Eyal Shamir; Yoram Barak; Irena Shalman; Moshe Laudon; Nava Zisapel; Ricardo Tarrasch; Avner Elizur; Ronit Weizman
Arch Gen Psychiatry 2001; 58: 1049-1052.
[Abstract]
[Full text]
[PDF]
- Original Articles
Cortical Serotonin Transporter Density and Verbal Memory in Individuals Who Stopped Using 3,4-Methylenedioxymethamphetamine (MDMA or "Ecstasy"): Preliminary Findings
- Liesbeth Reneman; Jules Lavalaye; Ben Schmand; Frederik A. de Wolff; Wim van den Brink; Gerard J. den Heeten; Jan Booij
Arch Gen Psychiatry 2001; 58: 901-906.
[Abstract]
[Full text]
[PDF]
- Commentaries
"Ecstasy" and Serotonin Neurotoxicity: New Findings Raise More Questions
- Una D. McCann; George A. Ricaurte; Mark E. Molliver
Arch Gen Psychiatry 2001; 58: 907-908.
[Extract]
[Full text]
[PDF]
- Original Articles
Efficacy of a Mixed Amphetamine Salts Compound in Adults With Attention-Deficit/Hyperactivity Disorder
- Thomas Spencer; Joseph Biederman; Timothy Wilens; Stephen Faraone; Jefferson Prince; Kristine Gerard; Robert Doyle; Asha Parekh; Jake Kagan; Sarah Kate Bearman
Arch Gen Psychiatry 2001; 58: 775-782.
[Abstract]
[Full text]
[PDF]
|
|
